New UK biotech fundraising initiative declared a win-win

February 10, 2005
Research and Development

Current rules which restrict how companies raise cash should be interpreted more freely to help UK biotech and other hi-tech …

Roche hepatitis and HIV combination approved

February 9, 2005
Sales and Marketing

Roche's Pegasys has become the first treatment licensed for patients suffering hepatitis C and HIV at the same time.The European …

Sanofi-Aventis sponsor cardiovascular research centre

February 9, 2005
Sales and Marketing

A new UK centre specialising in research into cardiovascular disease has opened its doors at St Mary's Hospital in Paddington, …

Schering launches new dermatology company

February 8, 2005
Sales and Marketing

German pharma company Schering has created a new, independent group, Intendis, focused on developing and marketing dermatology products.Intendis' new management …

Audit service launched to judge pharma marketing success

February 8, 2005

Marketing consultants Q2 Audit have launched a service to measure pharma's marketing effectiveness and give an indication of future product …

Rare side-effect warnings for Strattera

February 8, 2005
Sales and Marketing

UK health professionals have been warned  about rare but serious liver problems observed in Lilly's Strattera.The drug has been licensed …

Connecting with patients

February 8, 2005
Medical Communications

In order for a clinical trial to be viable, it needs patients. Sounds obvious, but despite the fact that patients …

New depression treatment launched in the UK

February 3, 2005
Sales and Marketing

Lilly and Boehringer Ingelheim's depression treatment Cymbalta has been launched in the UK where it will do battle in the …

New ‘economic damage’ offence to beat animal activists

February 3, 2005
Sales and Marketing

The government has unveiled new laws to counteract the intimidation tactics used by activists to undermine animal research. Animal rights …

‘Smarter steroid’ Alvesco launched in the UK

February 3, 2005
Sales and Marketing

Alvesco, the first one puff, once-daily inhaled corticosteroid for asthma has been launched in the UK, its first European market.Manufacturers …

Aspirin plus PPI better than Plavix in patients with GI bleed

February 2, 2005
Sales and Marketing

A new study has concluded that aspirin plus a proton pump inhibitor (PPI) is more effective than Plavix (clopidogrel) in …

BMJ apologises for Prozac accusations

February 2, 2005
Sales and Marketing

The BMJ has retracted its allegations that Eli Lilly suppressed important safety information on its antidepressant drug Prozac during litigation …

AstraZeneca remains strong despite setbacks

February 1, 2005
Sales and Marketing

AstraZeneca has announced impressive full-year figures for 2004 despite its market value slumping by nearly a third in the past …

Merck hit by US patent blow

February 1, 2005
Sales and Marketing

Merck has lost 10 years of US patent protection for the best-selling formulation of its second-biggest selling drug, following a …

Overdose deaths lead to co-proxamol withdrawal

February 1, 2005
Sales and Marketing

Co-proxamol, a commonly prescribed painkiller, will be withdrawn from use in the UK because of continued deaths from overdose.The drug …

Changing the headlines

February 1, 2005
Medical Communications

'You kill people, don't you?' someone said to me when I mentioned my job was in pharma market research. Statements …

NHS Trust – can pharma win it?

February 1, 2005

Sometimes pharma companies could be forgiven for thinking they are in a catch-22 situation. On the one hand local NHS …

Open up to expert patients

January 28, 2005
Medical Communications

The pharma industry has a crucial role to play in the successful roll-out of the Expert Patients Programme (EPP) and …

The Gateway to Local Adoption Series

Latest content